Keywords: Covidien, Mallinckrodt, Pharma business, Spin-off

Covidien files Form 10 registration statement for planned spin-off of Pharma business

Article | 04 February 2013

Ireland-based medical products and generic drugmaker Covidien (NYSE: COV) has announced the initial filing by Mallinckrodt of a Form 10 registration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Covidien

Mallinckrodt

Go to company listing